Mary Garofalo

1.6k citations
16 papers · 673 indexed · h-index 12
Topics
Immunodeficiency and Autoimmune Disorders (5 papers)T-cell and B-cell Immunology (4 papers)Immune Cell Function and Interaction (4 papers)
Partner nations
United StatesFranceCuba

In The Last Decade

Mary Garofalo

16 papers receiving 667 citations

Peers

Mary Garofalo
Comparison fields: 5 of 76
  • Immunology 331
  • Molecular Biology 218
  • Genetics 188
  • Oncology 171
  • Hematology 82
Replace Nienke de Graeff with:
Nienke de Graeff Netherlands
Jennifer Stoddard United States
Elizabeth Feldman United States
S Bosković United States
Fernanda S. G. Kehdy Brazil
Mariam Khalil United States
Antonella Isgrò Italy
Paola Quarello Italy
Manuela Moraru Spain
Mary Garofalo relative to Nienke de Graeff Netherlands Nienke de Graeff's profile →
Citations per field
00.5×10.7×
Nienke de Graeff · 1×
Citations per year

Countries citing papers authored by Mary Garofalo

Since Specialization
Citations

This map shows the geographic impact of Mary Garofalo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mary Garofalo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mary Garofalo more than expected).

Fields of papers citing papers by Mary Garofalo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mary Garofalo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mary Garofalo. The network helps show where Mary Garofalo may publish in the future.

Co-authorship network of co-authors of Mary Garofalo

This figure shows the co-authorship network connecting the top 25 collaborators of Mary Garofalo. A scholar is included among the top collaborators of Mary Garofalo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mary Garofalo. Mary Garofalo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
#WorkIndexed citations
1 26
2 11
3 52
4 195
5 50
6 2
7 43
8 7
9 29
10 95
11 38
12 1
13 52
14 44
15 12
16 16

About Mary Garofalo

Mary Garofalo is a scholar working on Immunology, History and Oncology, having authored 16 papers that have together received 673 indexed citations. Recurring topics across this work include Immunodeficiency and Autoimmune Disorders (5 papers), T-cell and B-cell Immunology (4 papers) and Immune Cell Function and Interaction (4 papers). The work is most often cited by research in Immunology (331 citations), Business and International Management (24 citations) and Issues, ethics and legal aspects (11 citations). Mary Garofalo has collaborated with scholars based in United States, France and Cuba. Frequent co-authors include Elizabeth Fee, Harry L. Malech, Douglas B. Kuhns, Kol A. Zarember, Julie E. Niemela, Jennifer Stoddard, Sergio D. Rosenzweig, Uimook Choi, Susan Moir and Suk See De Ravin. Their work appears in journals such as The Journal of Experimental Medicine, Blood and American Journal of Public Health.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026